CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND HEALTH CARE UTILIZATION IN ER+/HER2-METASTATIC POSTMENOPAUSAL BREAST CANCER PATIENTS: RESULTS FROM A RETROSPECTIVE MEDICAL RECORD REVIEW IN THE UNITED STATES

被引：0
|
作者：
Zanotti, G. [1 ]
Hunger, M. [2 ]
Perkins, J. J. [1 ]
Horblyuk, R. [1 ]
Martin, M. [3 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Mapi Grp, Munich, Germany
[3] Mapi Grp, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1646
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN24
引用
收藏
页码：A137 / A138
页数：2
相关论文
共 50 条
  • [1] PATIENT CHARACTERISTICS AND TREATMENT PATTERNS IN ER+/HER2-METASTATIC BREAST CANCER IN THE UK: RESULTS FROM A RETROSPECTIVE MEDICAL RECORD REVIEW
    Kurosky, S.
    Mitra, D.
    Zanotti, G.
    Kaye, J. A.
    VALUE IN HEALTH, 2015, 18 (07) : A492 - A492
  • [2] REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN ER+/HER2-METASTATIC BREAST CANCER: RESULTS FROM A MULTICOUNTRY RETROSPECTIVE MEDICAL RECORD REVIEW
    Mitra, D.
    Kurosky, S.
    Zanotti, G.
    Kaye, J. A.
    VALUE IN HEALTH, 2016, 19 (03) : A137 - A137
  • [3] Treatment Patterns and Outcomes of Patients With Metastatic ER+/HER-2- Breast Cancer: A Multicountry Retrospective Medical Record Review
    Kurosky, Samantha K.
    Mitra, Debanali
    Zanotti, Giovanni
    Kaye, James A.
    CLINICAL BREAST CANCER, 2018, 18 (04) : E529 - E538
  • [4] BUDGET IMPACT ANALYSIS OF EVEROLIMUS FOR ER+, HER2-METASTATIC BREAST CANCER PATIENTS IN THE UNITED STATES
    Xie, J.
    Diener, M.
    De, G.
    Wu, E. Q.
    Namjoshi, M.
    VALUE IN HEALTH, 2012, 15 (04) : A212 - A212
  • [5] Vaginal and sexual health in patients with ER+/HER2-metastatic breast cancer (mBC)
    Shanahan, Kelly
    Sammons, Sarah
    Meisel, Jane L.
    Pluard, Timothy J.
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1296 - 1296
  • [6] Treatment patterns and clinical outcomes in ER+/HER2-metastatic breast cancer in German real world settings
    Mitra, D.
    Kurosky, S.
    Kaye, J.
    Harbeck, N.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S141 - S141
  • [7] Treatment patterns and real world clinical outcomes in ER+/HER2-post-menopausal metastatic breast cancer patients in the United States
    Zanotti, Giovanni
    Hunger, Matthias
    Perkins, Julia J.
    Horblyuk, Ruslan
    Martin, Monique
    BMC CANCER, 2017, 17
  • [8] Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
    Giovanni Zanotti
    Matthias Hunger
    Julia J Perkins
    Ruslan Horblyuk
    Monique Martin
    BMC Cancer, 17
  • [9] Treatment goals and quality of life (QOL) in a survey of patients with ER+/HER2-metastatic breast cancer (mBC)
    Sammons, Sarah L.
    Meisel, Jane
    Shanahan, Kelly
    Pluard, Timothy
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    CANCER RESEARCH, 2023, 83 (05)
  • [10] HER2 mutations detected by ctDNA in ER+/HER2-metastatic breast cancer patients: Incidence and impact on clinical outcomes
    Medford, Arielle
    Juric, Dejan
    Niemierko, Andrzej
    Malvarosa, Giuliana
    Park, Hannah
    Shellock, Maria
    Spring, Laura
    Moy, Beverly
    Isakoff, Steven
    Ellisen, Leif
    Bardia, Aditya
    CANCER RESEARCH, 2018, 78 (04)
12345